On June 8, 2009, House Energy and Commerce Committee Chairman Henry Waxman wrote to President Obama asking "the Administration to consider what steps can be taken under existing authority to prepare and even begin to use a pathway for generic biologics." The letter also requests that the "Administration provide an analysis of long-term savings generated from generic biologics not only for Medicare and Medicaid, but also for businesses, insurers, and families."